Advisors Asset Management Inc. has strengthened its position in McDonald’s Corporation, increasing its stake by 7.5% in the first quarter. Recent filings with the Securities & Exchange Commission show the fund purchased an additional 2,799 shares, bringing its total holdings to nearly 40,000 shares, valued at $12.46 million.

Bridgeway Capital Management LLC reduced its stake in Crescent Energy Company by 3.1% during the first quarter, selling 54,826 shares. The firm now holds over 1.7 million shares, according to its most recent SEC filing.

Brigade Capital Management LP has acquired 910,000 shares of Service Properties Trust (SVC), valued at $2.38 million, according to a recent 13F filing. This purchase highlights the firm’s growing interest in the real estate investment trust sector.

Allostery Investments LP made a notable move in the biotech sector by acquiring 4,750 shares of Legend Biotech, valued at about $161,000. This transaction, carried out during the first quarter, aligns with ongoing institutional interest in Legend Biotech Corporation.

A new Citi survey reveals that Wall Street executives expect digital assets to secure a 10% share of the post-trade market by 2030. This shift could translate to an estimated $2 trillion in daily trading volume, driven in part by the rise of tokenized securities.

With critical FX option expiries hovering between 1.1590-00 and 1.1675-80, EUR/USD may find itself constrained. Yet, investors remain alert for surprises from global bond yields, which could quickly challenge this cautious calm in the forex market.

Elliott Investment Management has acquired a $4 billion stake in PepsiCo, citing an opportunity to reinvigorate the iconic snack and drink producer. The move underscores the activist investor’s confidence in PepsiCo’s potential to expand and innovate.

Regeneron Pharmaceuticals has struggled to keep pace with the broader pharma market over the past year. Despite this underperformance, analysts see potential for growth, citing reasons for continued optimism.

Forvia has announced its plan to offer 500 million euros in Senior Notes, scheduled to mature in 2031. This offering comes with critical legal restrictions, barring distribution to individuals or entities in the United States.

Gold made history by breaking above $3,500, giving investors a glimmer of optimism on an otherwise turbulent day for global markets. Stocks tumbled, oil fluctuated, and political remarks added to the uncertainty as traders navigated a risk-off environment.

Morgan Stanley and Cantor Fitzgerald have recently revised their views on Ryan Specialty. Within a few weeks, one firm lowered its price target while the other delivered an upgrade, indicating a changing landscape for the company’s stock.

Stocks pulled back on Tuesday amid global bond market anxiety and a recently announced tariff ruling against Donald Trump. The combination of international economic concerns and political developments contributed to sudden fluctuations in overall investor sentiment.

ADAR1 Capital Management LLC has increased its stake in Inhibikase Therapeutics, Inc. by 0.4%, bringing its total holdings to over five million shares. The institutional investor’s move indicates growing confidence in the biotech firm, which now comprises about 2.1% of ADAR1’s portfolio.

ADAR1 Capital Management LLC recently scaled down its investment in Mineralys Therapeutics, Inc. by 68.7%, selling over half a million shares. The firm now holds 263,425 shares, valued at approximately $4.18 million at the close of the first quarter.

In a notable first-quarter move, ADAR1 Capital Management LLC boosted its stake in Helix Acquisition Corp. II by 16.2%. The investment firm purchased an additional 65,591 shares, bringing its total holdings to 469,729 shares, according to a recent SEC filing.

Alkeon Capital Management LLC raised its holdings in Rubrik, Inc. by 40%, adding 200,000 shares during the first quarter. This move, revealed in the firm’s SEC filing, brings Alkeon’s total Rubrik ownership to 700,000 shares.

In a slight adjustment to its portfolio, Alkeon Capital Management LLC sold 348 shares of Yum! Brands, Inc. during the first quarter, representing a 0.1% reduction in its position. Despite the sale, Alkeon remains a significant stakeholder, with 465,603 shares valued at $73,267,000.

Advent International L.P. has expanded its investment in Carpenter Technology Corporation, revealing a 12.1% increase in shares during the first quarter. The firm’s latest Form 13F filing shows 87,186 newly acquired shares, bringing its total holdings to 804,832.

ADAR1 Capital Management LLC has strengthened its position in KALA BIO, Inc. with a notable 35.7% increase in shareholdings. The firm’s total stake now stands at nearly 299,000 shares valued at $1.7 million, reflecting heightened confidence in KALA BIO’s prospects.

ADAR1 Capital Management has significantly raised its stake in Contineum Therapeutics, increasing its shareholding by 105.2% in the first quarter. The purchase brings its total shares in the biotech company to 168,765, valued at approximately $1.18 million.

Alkeon Capital Management LLC has reduced its holdings in New Oriental Education & Technology Group by 16.4% in the first quarter, according to its latest SEC filing. Despite this decrease, the institutional investor still retains over one million shares of the company’s stock, indicating an ongoing interest in the education sector.